Ophthalmology News

Ophthal

sponsor

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Jamal KN et al. - In vivo pharmacokinetics as well as ocular distribution and metabolism are discussed, followed by a comprehensive summary of phase I, II, and III clinical trials evaluating safety and efficacy in patients suffering from postoperative inflammation or anterior uveitis. The objective is to provide an increased familiarity with this newly approved medication as a welcome addition to the ophthalmologist's armamentarium.

Related Articles

Tubulointerstitial nephritis and uveitis syndrome
Current Opinion in Ophthalmology, 10/27/09    Relevance Score: 89%

Intravitreal loading injection of ganciclovir with or without adjunctive oral valganciclovir for cytomegalovirus anterior uveitis
Graefe's Archive for Clinical and Experimental Ophthalmology, 10/02/09    Relevance Score: 89%

Cataract Surgery Under Infliximab Therapy in a Patient With Behcet's Disease
Journal of Ocular Pharmacology and Therapeutics, 10/30/09    Relevance Score: 87%

Uveitis-like syndrome and iris transillumination after the use of oral moxifloxacin
Eye, 10/26/09    Relevance Score: 87%

General Principles for the Treatment of Non-Infectious Uveitis
Inflammation & Allergy - Drug Targets, 10/09/09    Relevance Score: 87%

Today in Clinical Pharmacology...keeping you current

Intravitreal Bevacizumab and Ranibizumab for Age-Related Macular Degeneration: A Multicenter, Retrospective Study
Ophthalmology, 12/15/09

Triamcinolone Acetonide Injection for Persistent Atypical Idiopathic Orbital Inflammation
Orbit - The International Journal on Orbital Disorders, Oculoplastic and Lacrimal Surgery, 12/11/09

Intravitreal Combination of Triamcinolone Acetonide and Bevacizumab (Kenacort-Avastin) in Diffuse Diabetic Macular Edema
Seminars in Ophthalmology, 12/10/09